cerium has been researched along with Angiogenesis, Pathologic in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amal, R; Gunawan, C; Lord, MS; Teoh, WY; Tsoi, B; Whitelock, JM | 1 |
| Cai, X; McGinnis, JF; Seal, S | 1 |
| Al-Wahab, Z; Chhina, J; Dar, S; Das, S; Giri, S; Gupta, A; Hijaz, M; Mert, I; Munkarah, A; Rattan, R; Seal, S; Tebbe, C | 1 |
| Babu K, N; Chaudhury, K; Das, S; Kumar, A; Seal, S; Singh, AK | 1 |
| Alili, L; Brenneisen, P; Carroll, KS; Das, S; Giri, S; Sack, M; Seal, S; von Montfort, C; Zanger, K | 1 |
| Giri, S; Graham, RP; Karakoti, A; Maguire, JL; Rattan, R; Reilly, CM; Seal, S; Shridhar, V | 1 |
6 other study(ies) available for cerium and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Anti-angiogenic activity of heparin functionalised cerium oxide nanoparticles.
Topics: Angiogenesis Inhibitors; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cerium; Endothelial Cells; Heparin; Humans; Lysosomes; Nanoparticles; Neovascularization, Pathologic; Propylamines; Reactive Oxygen Species; Signal Transduction; Silanes | 2013 |
Sustained inhibition of neovascularization in vldlr-/- mice following intravitreal injection of cerium oxide nanoparticles and the role of the ASK1-P38/JNK-NF-κB pathway.
Topics: Animals; Cerium; Gene Expression Regulation; MAP Kinase Kinase Kinase 5; Mice; Mice, Inbred C57BL; Mice, Knockout; Nanoparticles; Neovascularization, Pathologic; NF-kappa B; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Polymerase Chain Reaction; Receptors, LDL; Vitreous Body | 2014 |
Folic acid tagged nanoceria as a novel therapeutic agent in ovarian cancer.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cerium; Cisplatin; Female; Folate Receptor 1; Folic Acid; Gene Expression Regulation, Neoplastic; Humans; Mice; Nanoparticles; Neovascularization, Pathologic; Ovarian Neoplasms; Xenograft Model Antitumor Assays | 2016 |
Mitigation of endometriosis using regenerative cerium oxide nanoparticles.
Topics: Animals; Antigens, CD34; Antioxidants; Biomarkers; Cell Line; Cerium; Endometriosis; Endometrium; Female; Humans; Lipid Peroxides; Mice; Microscopy, Fluorescence; Nanoparticles; Neovascularization, Pathologic; Oocytes; Oxidation-Reduction; Oxidative Stress; Particle Size; Reactive Oxygen Species | 2013 |
Downregulation of tumor growth and invasion by redox-active nanoparticles.
Topics: Animals; Antineoplastic Agents; Apoptosis; Caveolin 1; Cell Line, Tumor; Cell Proliferation; Cerium; Down-Regulation; Fibroblasts; Humans; Melanoma; Mice; Mice, Nude; Nanoparticles; Neoplasm Invasiveness; Neovascularization, Pathologic; Oxidation-Reduction; Protein Carbonylation; Reactive Oxygen Species; Skin Neoplasms; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |
Nanoceria: a rare-earth nanoparticle as a novel anti-angiogenic therapeutic agent in ovarian cancer.
Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cerium; Disease Models, Animal; Endothelial Cells; Female; Humans; Mice; Mice, Nude; Nanoparticles; Neoplasm Metastasis; Neovascularization, Pathologic; Ovarian Neoplasms; Reactive Oxygen Species; Signal Transduction; Tumor Burden; Vascular Endothelial Growth Factors | 2013 |